Q1 Earnings Review: Healthy Revenue Increases, Smaller Profit Growth
publication date: May 23, 2011
It's earnings season, and almost every day for the past few weeks, one to three China life science companies listed in the US have released their quarterly financial reports. Taken as a whole, companies from this sector have almost uniformly reported higher revenues. Net income has also risen, though usually by a lower percentage. The two largest companie in the groups, Mindray Medical and WuXi PharmaTech, continue to impress with strong gains. Price/Earnings ratios are lower than they were a few years ago, ranging from 31 down to a lowly 1.4. We give snapshots of the sixteen companies that have released reports so far this month. More details....
Stock Symbols: (NYSE: MR) (NYSE: WX)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.